The stock price of Travere Therapeutics Inc (NASDAQ: TVTX) has jumped by 10.57 compared to previous close of 9.93. Despite this, the company has seen
Additionally, the 36-month beta value for TVTX is 0.71. There are mixed opinions on the stock, with 6 analysts rating it as a “buy,” 5
Moreover, the 36-month beta value for TVTX is 0.71. Analysts have varying opinions on the stock, with 6 analysts rating it as a “buy,” 5
In the past week, TVTX stock has gone up by 1.88%, with a monthly decline of -11.15% and a quarterly surge of 31.47%. The volatility
In the past week, TVTX stock has gone up by 2.93%, with a monthly decline of -14.67% and a quarterly surge of 29.12%. The volatility
Moreover, the 36-month beta value for TVTX is 0.74. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 0
The stock of Travere Therapeutics Inc (TVTX) has gone down by -1.24% for the week, with a 15.22% rise in the past month and a
The 36-month beta value for TVTX is also noteworthy at 0.81. There are mixed opinions on the stock, with 0 analysts rating it as a
© 2024, Powered by Smart TechOne
